Baxter Hlthcare Corp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAXTER HLTHCARE CORP, and what generic alternatives to BAXTER HLTHCARE CORP drugs are available?
BAXTER HLTHCARE CORP has sixty-five approved drugs.
There are fifteen US patents protecting BAXTER HLTHCARE CORP drugs. There is one tentative approval on BAXTER HLTHCARE CORP drugs.
There are eight patent family members on BAXTER HLTHCARE CORP drugs in seven countries and one hundred and twenty-two supplementary protection certificates in fourteen countries.
Summary for Baxter Hlthcare Corp
International Patents: | 8 |
US Patents: | 15 |
Tradenames: | 77 |
Ingredients: | 51 |
NDAs: | 65 |
Drugs and US Patents for Baxter Hlthcare Corp
Expired US Patents for Baxter Hlthcare Corp
International Patents for Baxter Hlthcare Corp Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 3070798 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2021183752 | ⤷ Try a Trial |
Australia | 2021233893 | ⤷ Try a Trial |
Brazil | 112022015170 | ⤷ Try a Trial |
Canada | 3170514 | ⤷ Try a Trial |
Japan | 2023517926 | ⤷ Try a Trial |
China | 115243675 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Baxter Hlthcare Corp Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1499331 | 122014000007 | Germany | ⤷ Try a Trial | PRODUCT NAME: NATRIUMSULFAT, MAGNESIUMSULFAT UND KALIUMSULFAT; NAT. REGISTRATION NO/DATE: 86203.00.00 20130808; FIRST REGISTRATION: BELGIEN BE434323 20130220 |
0107734 | 93C0042 | Belgium | ⤷ Try a Trial | PROD. NAME TETRAKIS (2-METHOXY-ISOBUTYL-ISONITRILE). CUIVRE (I) TETRAFLUOROBORATE, DIHYDRATE DE CHLORURE STANNEUX, CHLORHYDRATE DE L-CYSTEINE (MONOHYDRATE); REG NO/DATE 923 IS 3 F 12/ 19900924 ; FIRST REG CC NO DATE IE PA 200/9/1 19900817 |
1534313 | 122015000111 | Germany | ⤷ Try a Trial | PRODUCT NAME: PHENYLEPHRIN UND KETOROLAC; REGISTRATION NO/DATE: EU/1/15/1018 20150728 |
1189916 | 1190003-2.L | Sweden | ⤷ Try a Trial | PRODUCT NAME: REGADENOSON OCH SALTER DAERAV; REG. NO/DATE: EU/1/10/643/001 20100906 |
1411900 | 2011C/016 | Belgium | ⤷ Try a Trial | PRODUCT NAME: NAPROXENE ET ESOMEPRAZOLE (SOUS LA FORME D'ESOMEPRAZOLE MAGNESIUM TRIHYDRATE); AUTHORISATION NUMBER AND DATE: BE382505 20101214 |
1189916 | SZ 2/2011 | Austria | ⤷ Try a Trial | PRODUCT NAME: REGADENOSON UND DESSEN SALZE |
0521471 | SPC/GB03/033 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ROSUVASTATIN OPTIONALLY IN THE FORM OF A NON-TOXIC PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE CALCIUM SALT.; REGISTERED: NL 26872 20021106; NL 26873 20021106; NL 26874 20021106; UK PL 17901/0201 20030321; UK PL 17901/0202 20030321; UK PL 17901/0203 20030321 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.